High performance liquid chromatography-electrospray ionization mass spectrometric determination of tolterodine tartrate in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 824, Issue 1-2, 2005, Pages 92-98

  Zhang, Beibei ^a   Zhang, Zunjian ^a   Tian, Yuan ^a   Xu, Fengguo ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

HPLC ESI MS; Human plasma; Pharmacokinetics; Tolterodine tartrate

Indexed keywords

ACETONITRILE; CONCENTRATION (PROCESS); ENZYMES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IONIZATION; MASS SPECTROMETRY; PHARMACOKINETICS; WATER;

HPLC-ESI-MS; HUMAN PLASMA; SELECTED-ION-MONITORING (SIM); TOLTERODINE TARTRATE;

PLASMAS;

2 PROPANOL; ACETONITRILE; HEXANE; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; TOLTERODINE; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANALYTIC METHOD; ARTICLE; BIOEQUIVALENCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DETERMINATION; ELECTROSPRAY MASS SPECTROMETRY; EVAPORATION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSTRUMENTATION; ION MONITORING; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STANDARD; VALIDATION PROCESS;

ADMINISTRATION, ORAL; AREA UNDER CURVE; BENZHYDRYL COMPOUNDS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRESOLS; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 24044453421     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2005.07.010     Document Type: Article

References (9)

1. L. Nilvebrant, B. Hallen, and G. Larsson Life Sci. 60 1997 1129
2. E.S. Rovner, and A.J. Wein Eur. Urol. 41 2002 6
3. L. Nilvebrant Life Sci. 68 2001 2549
4. B. Ollson, and J. Szamosi Clin. Pharmacokinet. 40 2001 227
5. Y.R. Kumar, G. Ralamu, V.V. Vevakanand, G. Vaidyanathan, K. Srinivas, M.K. Kumara, K. Mukkanti, M.S. Reddya, S. Venkatraman, and M.V. Suryanarayana J. Pharm. Biomed. Anal. 35 2004 1279
6. L. Palmer, L. Andersson, T. Andersson, and U. Stenberg J. Pharm. Biomed. Anal. 16 1997 155
7. R. Swart, P. Koivisto, and K.E. Markides J. Chromatogr. A 828 1998 209
8. R. Swart, P. Koivisto, and K.E. Markides J. Chromatogr. B 736 1999 247
9. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), May 2001.